CYP21A2 and congenital adrenal hyperplasia: Accordingly, having guidelines for the carrier screening of congenital adrenal hyperplasia and preconception and prenatal screening programs for CYP21A2 mutations seems to be the requisite in Northern Cyprus considering the preventive medicine strategies on the island.